.
BioEnterprise

NeuroTherapia Receives Investment from Alzheimer’s Drug Discovery Foundation

NeuroTherapia, a Cleveland Clinic spinoff company, has received a $1.7 million commitment from the Alzheimer’s Drug Discovery Foundation to advance its Alzheimer’s therapy into clinical trials.

Read More  >